chr1-1436948-GA-G
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_022834.5(VWA1):c.96delA(p.Asp34fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 33)
Consequence
VWA1
NM_022834.5 frameshift
NM_022834.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.240
Genes affected
VWA1 (HGNC:30910): (von Willebrand factor A domain containing 1) VWA1 belongs to the von Willebrand factor (VWF; MIM 613160) A (VWFA) domain superfamily of extracellular matrix proteins and appears to play a role in cartilage structure and function (Fitzgerald et al., 2002 [PubMed 12062410]).[supplied by OMIM, Nov 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. There are 9 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 1-1436948-GA-G is Pathogenic according to our data. Variant chr1-1436948-GA-G is described in ClinVar as [Pathogenic]. Clinvar id is 2154860.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VWA1 | ENST00000476993.2 | c.96delA | p.Asp34fs | frameshift_variant | 2/3 | 1 | NM_022834.5 | ENSP00000417185.1 | ||
VWA1 | ENST00000471398.1 | c.216delA | p.Asp74fs | frameshift_variant | 2/2 | 3 | ENSP00000464343.1 | |||
VWA1 | ENST00000495558 | c.-10delA | 5_prime_UTR_variant | 2/2 | 2 | ENSP00000463643.1 | ||||
VWA1 | ENST00000338660.5 | c.74-373delA | intron_variant | 2 | ENSP00000423404.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 05, 2022 | This sequence change creates a premature translational stop signal (p.Asp34Thrfs*2) in the VWA1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in VWA1 are known to be pathogenic (PMID: 33459760). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with VWA1-related conditions. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.